doxapram has been researched along with Dyskinesia, Drug-Induced in 2 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxapram is a respiratory stimulating drug that affects both peripheral chemoreceptors and medullary respiratory and nonrespiratory neurons." | 5.26 | Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. ( Hunt, CE; Inwood, RJ; Shannon, DC, 1979) |
| "Doxapram is a respiratory stimulating drug that affects both peripheral chemoreceptors and medullary respiratory and nonrespiratory neurons." | 1.26 | Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome. ( Hunt, CE; Inwood, RJ; Shannon, DC, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dear, PR | 1 |
| Wheeler, D | 1 |
| Hunt, CE | 1 |
| Inwood, RJ | 1 |
| Shannon, DC | 1 |
2 other studies available for doxapram and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Doxapram and neonatal apnoea.
Topics: Apnea; Doxapram; Dyskinesia, Drug-Induced; Humans; Infant, Newborn | 1984 |
Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome.
Topics: Chemical and Drug Induced Liver Injury; Doxapram; Duodenal Ulcer; Dyskinesia, Drug-Induced; Humans; | 1979 |